Henry Featherstone

Head of Health Unit, 2008-2010


Henry now leads public affairs activity in the UK & Ireland for Genzyme Therapeutics, a leading bio-pharmaceutical company and part of the Sanofi Group.

Henry Featherstone

Related Posts & Publications

The Cost of Cancer

The Cost of Cancer

Read Publication The UK currently has a cancer death rate 6% higher than the European average.  However if the survival rates were improved in England to a level commensurate with the best in Europe, on a cumulative basis by 2020, 71,500 lives could be saved and total...
Hitting the bottle

Hitting the bottle

Read Publication Bank Holiday binge drinking is predicted to cost the NHS £25 million this weekend. Policy Exchange’s new report, Hitting the bottle recommends a fundamental overhaul of the alcohol duty regime, to allow for prices to be raised on super-strength...